Doctor Savvas Grigoriadis
General Hospital of Veria, Veria (Greece)
Assessment of three-dimensional echocardiography as a diagnostic tool for detecting chemotherapy-induced cardiotoxicity
Event: Heart Failure 2019
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
The relation of obstructive sleep apnea syndrome with acute coronary syndromes
Event: Heart Failure 2019
Topic: Sleep Disorders
Session: Risk factors and prevention
Three-dimensional ECHO in serial monitoring of patients undergoing Trastuzumab therapy
Event: Heart Failure 2019
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
The role of MPV in the prediction of CAD severity
Event: Acute Cardiovascular Care 2019
Topic: Inflammation
Session: Acute Coronary Syndromes - Pathophysiology and Mechanisms, Biomarkers , Treatment, Revascularization Poster Discussant
Comparison of methods for diagnosing Cardiotoxicity
Event: EuroEcho-Imaging 2018
Topic: 3D Echocardiography
Session: 3D Echocardiography
Comparison of methods used to assess left ventricular ejection fraction in patients on chemotherapy
Event: EuroEcho-Imaging 2018
Topic: 3D Echocardiography
Session: 3D Echocardiography
Variability of three-dimensional left ventricular ejection fraction in patients on chemotherapy
Event: EuroEcho-Imaging 2018
Topic: 3D Echocardiography
Session: 3D Echocardiography
Three-dimensional ejection fraction is the most accurate method for diagnosing trastuzumab-induced cardiotoxicity
Event: EuroEcho-Imaging 2018
Topic: 3D Echocardiography
Session: 3D Echocardiography
ESC 365 is supported by
